On July 27, 2016, Cubresa Inc., a medical imaging company that develops and markets nuclear imaging systems, The United States Patent and Trademark Office has issued US Patent 9,322,930, covering a novel arrangement of imaging sensors and methods for determining sensor positions for 3D imaging.
The new method describes mounting many imaging sensors underneath a flexible substrate could reveal tumors within humans or animals.
James Schellenberg, co-inventor and founder and CTO of Cubresa said “The best imaging places cameras as close as possible to the surface of the subject’s skin,” This has been a problem with humans and other live animals. For example, the curvature of a woman’s breast and underarm area, where imaging of cancer and lymph node involvement is needed, is topographically complex and will vary from woman to woman.”
To make the imaging flexible cubera places a large number of small imaging sensors under a flexible substrate which will be adjusted to fit the subject and the exact position of each sensor is determined, instead of mechanically rotating a camera or cameras around the area or having a person move a camera by hand. The sophisticated software algorithms create 3D images out of the many 2D images from each sensor.
The flexibility of the FPDs makes them suitable for the development of conformable detectors that can go around objects for non-destructive testing (NDT) or security applications. In addition, the ultra-low leakage advantage of OTFTs compared to amorphous silicon brings direct sensitivity benefits to X-ray detection.
Both preclinical and clinical application can use “Flexible imaging sensors“ said George Abe, Cubresa’s CEO. Abe says “Disease mechanisms are extraordinarily complex,” and we’re developing products with greater precision and resolution that can allow scientists and clinicians to achieve their goal of better understanding disease and developing more personalized therapies.
Keywords: Cubresa, flexible imaging sensors, Patent, nuclear imaging systems
